Clostridium butyricum and Reduced Bronchopulmonary Dysplasia Severity

• A Randomized Controlled Trial of Probiotic Intervention for Reducing the Risk of Bronchopulmonary Dysplasia in Preterm Infants.

  • 2026-07
  • RCT · n = 244
  • Archives of medical research 57(5)
  • • Dandan Wang
    • Shanshan Wang
    • Huijie Wang
    • Xuan Zhang

  • PubMed: 41895129
  • DOI: 10.1016/j.arcmed.2026.103408

  6 Insights on

  • Reduced Bronchopulmonary Dysplasia Severity

  • High evidence
  • Large Human Trial
  • Clinical

  a lower proportion of severe BPD cases in the intervention group

  Effect

  Beneficial

  Effect size

  Small

  Significant

  Yes